Share on LinkedInShare on LinkedIn

ARTICLE · 30 JUNE 2025

EU Restricts Chinese Access To Public Procurement Of Medical Devices

A&O Shearman
A&O Shearman
Contributor

A&O Shearman

Introducing A&O Shearman Unparalleled global depth for a changing world. Today more than ever,...

View firm profile
Explore more from A&O Shearman

Last Friday, the European Commission announced its first International Procurement Instrument (IPI) measure, excluding "economic operators" from China from participation in EU public procurement procedures...

GlobalGovernment, Public Sector

Last Friday, the European Commission announced its first International Procurement Instrument (IPI) measure, excluding "economic operators" from China from participation in EU public procurement procedures for medical devices with a value exceeding EUR5 million.

Background

This measure marks the first case in which the EU makes use of the IPI based on Regulation (EU) 2022/1031 (IPI Regulation). The IPI Regulation's objective is to create a level playing field in the global procurement market by empowering the EU to take countermeasures when non-EU countries restrict access to their own procurement markets or distort competition in EU-wide public procurement procedures by granting economic advantages.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from